For example, galacto-oligosaccharides can inhibit the progression of obesity and insulin resistance in mice by increasing the expression of intestinal glucagon-like peptide 1 (GLP1) and decreasing fecal bile acid excretion (Mistry et al., 2020). This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.